TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 5 | 13 | 13 | 31 | 73 | 36 | 28 |
| P | %wins | 100 | 100 | 100 | 100 | 67 | 67 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/16/11 10:48 | 8/12/11 | GNVC | Genvec Inc | DE | Health | Drug | Pharmaceutical Preparations | Fischer Paul H | MD | DO | P,CEO | P | 59 | 2.37 | 0 | 25 | 95 | 51 | D | -69 | -55 | -53 | -46 | -25 | -20 | 2 | 15 | 2 | 16 | 26 | 17 | 8 | -22 |
8/21/06 16:48 | 8/18/06 | GNVC | Genvec Inc | DE | Health | Drug | Pharmaceutical Preparations | Fischer Paul H | MD | DO | P,CEO | P | 5 | 0.9492 | 0 | 5 | 2 | 264 | D | -53 | -55 | -51 | -50 | -23 | -23 | -15 | -4 | 13 | 15 | 10 | 50 | 217 | 115 |
5/20/05 11:20 | 5/19/05 | GNVC | Genvec Inc | DE | Health | Drug | Pharmaceutical Preparations | Fischer Paul H | X1 | DO | C.E.O. | P | 9 | 1.75 | 0 | 5 | 2 | 229 | D | -35 | -43 | -4 | -20 | -13 | 1 | 1 | -1 | 1 | 7 | 2 | 27 | -6 | 14 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |